Literature DB >> 18832861

Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population.

Patricia Gassó1, Miquel Bernardo, Sergi Mas, Anna Crescenti, Clemente Garcia, Eduard Parellada, Amalia Lafuente.   

Abstract

BACKGROUND: Monoamine oxidase B (MAO-B) enzyme is involved in the oxidative metabolism of dopamine. We studied whether the A644G polymorphism in intron 13 of the MAO-B gene is a risk factor for schizophrenia.
METHODS: 242 subjects diagnosed with schizophrenia and related disorders and 290 hospital-based controls participated in the study. Genomic DNA was isolated from whole blood and genotyped with the allele-specific oligonucleotide polymerase chain reaction method.
RESULTS: This polymorphism was studied by diagnosis subgroups and the G allele was identified as a risk factor for developing schizophrenia (p = 0.006). When we performed a sex-specific analysis, the G allele was only a risk factor for developing schizophrenia in women (p = 0.01). Although the frequency of the G allele is higher in male patients than in male controls, no statistically significant association with schizophrenia was found.
CONCLUSION: Our results support the involvement of the MAO-B gene in schizophrenia, particularly in women. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832861     DOI: 10.1159/000159774

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  9 in total

1.  Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.

Authors:  A Piton; J Gauthier; F F Hamdan; R G Lafrenière; Y Yang; E Henrion; S Laurent; A Noreau; P Thibodeau; L Karemera; D Spiegelman; F Kuku; J Duguay; L Destroismaisons; P Jolivet; M Côté; K Lachapelle; O Diallo; A Raymond; C Marineau; N Champagne; L Xiong; C Gaspar; J-B Rivière; J Tarabeux; P Cossette; M-O Krebs; J L Rapoport; A Addington; L E Delisi; L Mottron; R Joober; E Fombonne; P Drapeau; G A Rouleau
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

Review 2.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

3.  A functional variant provided further evidence for the association of ARVCF with schizophrenia.

Authors:  Sergi Mas; Miquel Bernardo; Patricia Gassó; Santi Alvarez; Clemente Garcia-Rizo; Miquel Bioque; Brian Kirkpatrick; Amalia Lafuente
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

4.  Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese.

Authors:  Yi-Liang Wei; Cai-Xia Li; Sheng-Bin Li; Yao Liu; Lan Hu
Journal:  Behav Brain Funct       Date:  2011-10-06       Impact factor: 3.759

Review 5.  Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Front Behav Neurosci       Date:  2014-03-06       Impact factor: 3.558

6.  Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients.

Authors:  Ahmed M Salem; Samira Ismail; Waheba A Zarouk; Olwya Abdul Baky; Ahmed A Sayed; Sawsan Abd El-Hamid; Sohair Salem
Journal:  ScientificWorldJournal       Date:  2013-12-23

Review 7.  Emerging evidence for astrocyte dysfunction in schizophrenia.

Authors:  Eva Cristina de Oliveira Figueiredo; Corrado Calì; Francesco Petrelli; Paola Bezzi
Journal:  Glia       Date:  2022-05-30       Impact factor: 8.073

8.  Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.

Authors:  Dimitrios Andreou; Erik Söderman; Tomas Axelsson; Göran C Sedvall; Lars Terenius; Ingrid Agartz; Erik G Jönsson
Journal:  Behav Brain Funct       Date:  2014-07-29       Impact factor: 3.759

9.  The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia.

Authors:  Zoran Madzarac; Lucija Tudor; Marina Sagud; Gordana Nedic Erjavec; Alma Mihaljevic Peles; Nela Pivac
Journal:  Curr Issues Mol Biol       Date:  2021-07-08       Impact factor: 2.976

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.